Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Banting Postdoctoral Fellowship Program

Direct Payment

$140,000.00

Informing Policy Through Evidence: Applying Health Technology Assessment in Cardiac Electrophysiology to Disseminate High-Value Care

FY 2018-19

Summary
The past several decades have witnessed the emergence of disruptive technologies in the field of cardiac electrophysiology. New technologies have afforded clinicians exciting new opportunities to improve the quality and cardiac health of Canadians. Yet, these therapies attract scrutiny from health administrators and provincial policy-makers due to their associated upfront costs in the context of a healthcare system with finite resources. Health technology assessment is becoming ever more important in the field of electrophysiology as the rate of technologic innovation exceeds our fiscal ability to provide and deliver equitable care. In this research program, we endeavor to evaluate the economic impact of new technology within two important clinical domains in electrophysiology: (a) reduction of sudden cardiac death and (b) enhancing the detection of atrial fibrillation (AF). Project A is the economic substudy of the REFINE ICD ("Risk Estimation Following Infarction Noninvasive Evaluation-ICD efficacy") randomized trial. This substudy will assess the cost-effectiveness of extending primary prevention implantable cardioverter defibrillator (ICD) therapy to patients with lesser degrees of left ventricular dysfunction. Project B is a proposed economic evaluation of extended (>30 day) and long-term (>1 year) electrocardiographic (ECG) monitors for AF detection compared to the traditional short-term (<48 hr) monitor in patients stroke of unknown cause. Barriers to adoption of new technologies include the possible impact on health care budgets. This portfolio of projects will formally assess the economic impact of expanding the indication for ICDs (Project A) and the impact of newer ECG monitoring technology to reveal occult atrial fibrillation to treat and prevent recurrent stroke (Project B). Results from this program will be used to inform health care professionals, administrators, and government policy-makers to advocate for implementation of high value care.
Program
Banting Postdoctoral Fellowship Program
Location
North Carolina, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
392272
Name
Chew Derek
Region
North Carolina
Country
United States of America
Orgtype
Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
Informing Policy Through Evidence: Applying Health Technology Assessment in Cardiac Electrophysiology to Disseminate High-Value Care
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
Atrial Fibrillation; Cryptogenic Stroke; Health Economics; Health Technology Assessment; Implantable Cardioverter Defibrillator; Implantable Loop Recorder; Sudden Cardiac Death
Abstract
The past several decades have witnessed the emergence of disruptive technologies in the field of cardiac electrophysiology. New technologies have afforded clinicians exciting new opportunities to improve the quality and cardiac health of Canadians. Yet, these therapies attract scrutiny from health administrators and provincial policy-makers due to their associated upfront costs in the context of a healthcare system with finite resources. Health technology assessment is becoming ever more important in the field of electrophysiology as the rate of technologic innovation exceeds our fiscal ability to provide and deliver equitable care. In this research program, we endeavor to evaluate the economic impact of new technology within two important clinical domains in electrophysiology: (a) reduction of sudden cardiac death and (b) enhancing the detection of atrial fibrillation (AF). Project A is the economic substudy of the REFINE ICD ("Risk Estimation Following Infarction Noninvasive Evaluation-ICD efficacy") randomized trial. This substudy will assess the cost-effectiveness of extending primary prevention implantable cardioverter defibrillator (ICD) therapy to patients with lesser degrees of left ventricular dysfunction. Project B is a proposed economic evaluation of extended (>30 day) and long-term (>1 year) electrocardiographic (ECG) monitors for AF detection compared to the traditional short-term (<48 hr) monitor in patients stroke of unknown cause. Barriers to adoption of new technologies include the possible impact on health care budgets. This portfolio of projects will formally assess the economic impact of expanding the indication for ICDs (Project A) and the impact of newer ECG monitoring technology to reveal occult atrial fibrillation to treat and prevent recurrent stroke (Project B). Results from this program will be used to inform health care professionals, administrators, and government policy-makers to advocate for implementation of high value care.
Competitiondate
201809
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Chew, Derek
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~
Direct Payment - $140,000 Grant (2018-19) | Canada Spends